Blood disorder evolution: researchers track hidden transformation
NCT ID NCT07203768
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study examines why some patients with essential thrombocythemia (ET) later develop polycythemia vera (PV), a related blood condition. Researchers will review medical records of 678 adults to identify risk factors for this change and compare outcomes between those who progressed and those diagnosed with PV from the start. The goal is to better understand the disease course and improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL THROMBOCYTHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
12 Octubre University Hospital
RECRUITINGMadrid, Spain
-
A.S.O. SS. Antonio e Biagio e C.Arrigo, SC Ematologia
NOT_YET_RECRUITINGAlessandria, 15121, Italy
-
AOU Careggi, Divisione di Ematologia
RECRUITINGFlorence, Italy
-
ASST Grande Ospedale Metropolitano Niguarda, Divisione di Ematologia
NOT_YET_RECRUITINGMilan, Italy
-
ASST MONZA Ospedale San Gerardo Clinica Ematologica
NOT_YET_RECRUITINGMonza, 20900, Italy
-
ASST Papa Giovanni XXIII, SC Ematologia
RECRUITINGBergamo, Italy
-
ASST-Spedali Civili
NOT_YET_RECRUITINGBrescia, 25123, Italy
-
Azienda Ospedaliera Universitaria Federico II di Napoli Divisione di Ematologia e Trapianti del Midollo
NOT_YET_RECRUITINGNaples, 80131, Italy
-
Azienda Ospedaliera Universitaria Integrata - Ospedale Borgo Roma, Unità di Ematologia
NOT_YET_RECRUITINGVerona, Italy
-
Azienda Ospedaliero Universitaria Maggiore della Carità di Novara SCDU Ematologia
RECRUITINGNovara, 28100, Italy
-
Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo
NOT_YET_RECRUITINGPavia, Lombardy, 27100, Italy
-
Divisione Ematologia, Ospedale San Bortolo
RECRUITINGVicenza, Veneto, Italy
-
Fondazione IRCCS Cà Grande - Op. Maggiore Policlinico
NOT_YET_RECRUITINGMilan, Italy
-
Fondazione Policlinico Universitario Gemelli
RECRUITINGRoma, Italy
-
Guy's and St. Thomas' NHS Foundation Trust
RECRUITINGLondon, United Kingdom
-
Hannover Medical School
RECRUITINGHanover, Germany
-
IDIBAPS, Hospital clinic
RECRUITINGBarcelona, Spain
-
Mayo Clinic
ACTIVE_NOT_RECRUITINGRochester, Minnesota, 55905-0001, United States
-
Ospedale San Raffaele
NOT_YET_RECRUITINGMilan, Italy
-
Policlinico S. Orsola - Malpighi
NOT_YET_RECRUITINGBologna, Italy
-
Presidio Ospedaliero di Pescara
NOT_YET_RECRUITINGPescara, Italy
-
Umberto I Policlinico
NOT_YET_RECRUITINGRoma, Italy
-
University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center
RECRUITINGMinden, Germany
-
University Hospital Halle
NOT_YET_RECRUITINGHalle, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a hormone mimic curb the need for bloodletting in a blood cancer?
- Can a Dual-Action pill tame bone marrow tumors?
- Can a new drug reduce bloodletting for polycythemia vera?
- A simple Note-Taking change could transform blood cancer care
- Can a new drug help when standard treatment fails for polycythemia vera?
- Can a biologic drug outperform standard therapy for a rare blood cancer?